Green Planet Bio Engineering CO LTD 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
Green Planet Bioengineering Co., Ltd. filed its Q2 2026 10-Q, reporting continued shell corporation status with no active business operations and reliance on related party financing.
OTC.Pink
Green Planet Bioengineering Co., Ltd. reports continued operational inactivity and reliance on related party funding for Q1 2026, with a net loss of $10,944.
OTC.Pink
Green Planet Bioengineering Co., Ltd. filed its Q3 2025 10-Q, reporting continued net losses and a significant working capital deficit as a non-operating shell company.
OTC.Pink
Green Planet Bioengineering reports continued shell corporation status with no active operations and a significant accumulated deficit, raising going concern doubts.
OTC.Pink
10-Q: Green Planet Bioengineering Reports Minimal Activity in Q1 2025, Cites Going Concern Uncertainty
Green Planet Bioengineering Co., Ltd. reports a net loss of $6,840 for the quarter ended March 31, 2025, with continued reliance on related party funding and no active business operations.
OTC.Pink
Green Planet Bioengineering Co., Ltd. reports minimal activity and a net loss for the third quarter of 2024, with continued reliance on related party funding and going concern doubts.
OTC.Pink
Green Planet Bioengineering Co., Ltd. reports ongoing losses and no active business operations for the quarter ended June 30, 2024, relying on related party funding.
OTC.Pink
10-Q: Green Planet Bioengineering Reports Minimal Activity in Q1 2024, Relies on Related Party Funding
Green Planet Bioengineering Co., Ltd. reports no active business operations and a net loss of $6,465 for the quarter ended March 31, 2024, relying on funding from a related party.